Table 2. Differences in the proportion of antimicrobial drug resistance in 21 European countries, 2005, and significant trends, 2001–2005.
| Compound-pathogen† | Antimicrobial drug resistance |
|||||
|---|---|---|---|---|---|---|
| Europe, %, 2005 |
Trends, 2001–2005* |
|||||
| Maximum (country) | Minimum (country) | fd‡ | Increase (p<0.05) | Decrease (p<0.05) | ||
| PNSP | 36 (FR) | 1.3 (NL) | 27.7 | BG | ES, UK | |
| ENSP | 41 (FR) | 2 (CZ) | 20.5 | FI, HU, NL | ||
| FQRE | 29 (PT) | 3 (IS) | 9.7 | AT, BE, BG, CZ, DE, ES, FI, HR, HU, LU, NL, PT, SE | ||
*No trend analysis was performed for Denmark and France, and for Ireland and the United Kingdom for proportion of Escherichia coli resistant to fluoroquinolones (FQRE), because data were not available for all years of the study period (2001–2005). See Table 1 footnote for country designations. †PNSP, proportion of Streptococcus pneumoniae not susceptible to penicillin; ENSP, erythromycin-nonsusceptible S. pneumoniae. ‡fd, factor difference.